Ampath Labs in strategic partnership with Emami Frank Ross

IMT News Desk
IMT News Desk
· 2 min read

Expands customer touchpoints in Bengaluru

American Institute of Pathology & Laboratory Sciences (Ampath) is in strategic partnership with Emami Frank Ross, a retail pharmacy chain in India. This collaboration aims to extend customer touchpoints in Bangalore by offering high-quality pathology services through 10 Emami Frank Ross outlets in Bengaluru.

Ampath Labs and Emami Frank Ross will provide a convenient and accessible solution for patients requiring pathology services. This partnership will enable individuals to access a wide range of services at Emami Frank Ross pharmacies, ensuring that healthcare services are readily available in their local communities.

Dr Maneesh Bagai, COO, Ampath Labs, said, “We are delighted to collaborate with Emami Frank Ross and expand our customer touchpoints in Bangalore. This strategic alliance will enable us to bring our exceptional pathology services closer to the people, ensuring they receive timely and accurate diagnostic results. By leveraging Emami Frank Ross’ extensive network, we aim to enhance the accessibility and convenience of healthcare for individuals across the city.”

Gautam Jatia, MD, Emami Frank Ross, also shared his excitement about the collaboration, stating, “At Emami Frank Ross, we have always been committed to providing holistic healthcare solutions to our customers. Our partnership with Ampath Labs aligns perfectly with this vision, as it allows us to offer top-notch pathology services alongside our existing pharmaceutical offerings. We believe this collaboration will significantly benefit the people of Bengaluru by bringing advanced diagnostics right to their doorstep.”

The strategic partnership between Ampath Labs and Emami Frank Ross underscores both companies’ dedication to delivering exceptional healthcare services and improving patient outcomes. By leveraging their respective expertise, resources, and extensive networks, they aim to make healthcare more accessible, convenient, and reliable for the residents of Bengaluru.

Read Next

Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Larotrectinib Capsules
News
June 11, 2026

Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Larotrectinib Capsules

Alembic Pharmaceuticals Limited (Alembic) announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Larotrectinib Capsules, 25 mg and 100 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Vitrakvi Capsules, 25 mg and 100 mg, of […]
Article by: IMT News Desk
DFE Pharma earns third consecutive EcoVadis Gold Medal for sustainability performance 
News
June 11, 2026

DFE Pharma earns third consecutive EcoVadis Gold Medal for sustainability performance 

DFE Pharma has earned its third consecutive Gold Medal from EcoVadis, the world leader in corporate sustainability assessments, in recognition of its strong performance in the four themes rated: Environment, Labor & Human Rights, Ethics and Sustainable Procurement. This distinction places DFE Pharma in the top 5% of companies, reflecting the company’s focused efforts to […]
Article by: IMT News Desk
Oval Fertility Inks MoU with Merck to Advance Reproductive Care Standards in India
News
June 11, 2026

Oval Fertility Inks MoU with Merck to Advance Reproductive Care Standards in India

Oval Advanced Fertility Care and Merck Specialities Private Limited, the Indian healthcare arm of Merck KGaA, Darmstadt, Germany and a global leader in fertility sciences with decades of scientific leadership in reproductive medicine, have signed a strategic Memorandum of Understanding (MOU).   India’s IVF market, valued at approximately USD 2.35 billion in 2024, is projected […]
Article by: IMT News Desk
Infosys-backed 4baseCare raises ₹128 crore, plans to take its cancer testing platform global
News
June 11, 2026

Infosys-backed 4baseCare raises ₹128 crore, plans to take its cancer testing platform global

Bengaluru-based precision oncology startup 4baseCare has raised ₹128 crore in its ongoing Series B funding round to expand its hospital-linked genomics laboratory network globally and scale its AI-powered precision oncology platform, OncoTwin. The latest funding round, which follows a first close of ₹90 crore co-led by Ashish Kacholia and Lashit Sanghvi with participation from existing […]
Article by: IMT News Desk